The diagnosis of AKI-HRS is made in cases of non-response to this volume expansion, and vasoactive drugs and albumin at the dosage of 20–40 g/day must be initiated to improve renal perfusion and dampen inflammation [40,41]. Here, ALB is linked to acute kidney injury.